Kennard William E 4

What Happened
William E. Kennard, a director of MetLife, received an award/acquisition of 322 shares of MetLife common stock on 2026-06-09 at an imputed price of $85.57 per share, a total value of $27,554. This transaction reflects shares becoming payable and being deferred rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-09; Filing date (Form 4): 2026-06-11 (appears timely under the 2-business-day rule).
• Shares acquired: 322 at $85.57 per share; total value ~$27,554.
• Shares owned after transaction: not specified in the filing.
• Footnote F1: Imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors (these are shares that became payable but were deferred).
• Footnote F2: Notes shares may be held in trust under the MetLife Policyholder Trust for eligible policyholders.
• Transaction type: Award/acquisition (code A) — not a sale or exercise; treated as director compensation/deferral.

Context
Deferred-share awards or dividend reinvestments for directors are routine compensation/deferral mechanisms and do not necessarily signal the director’s view on the stock. This was not a sale or option exercise and does not indicate immediate market activity by the director.